Monthly Archives: October 2023

Personalized treatments – Phosphoproteomics research reveals new avenues for developing targeted therapies for patients with pancreatic cancer

  • October 3, 2023
  • Comments off

In our recent study pubished in Cell Reports, PhD student Andrea Valles shows how profile-guided phosphoproteomics can be used to select low dose combination treatment based on three kinase inhibitors. Kinase activity ranking of individual cell lines using our INKA pipeline,¬†provided the rationale for a combination of within pathway and parallel pathway targeting with triple¬† […]

Read More